BAY-1895344
1876467-74-1
DY444700
C20H21N7O
375.427
(R)-3-methyl-4-(4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl)morpholine
| Chemical Name | BAY-1895344 |
|---|---|
| CAS Number | 1876467-74-1 |
| Molecular Formula | C20H21N7O |
| Molecular Weight | 375.427 |
| Synonyms | (R)-3-methyl-4-(4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl)morpholine |
BAY-1895344 is a selective ATR (ataxia-telangiectasia and Rad3 related protein) inhibitor that inhibits proliferation of a broad spectrum of human tumor cell lines (median IC50 = 78 nM). BAY-1895344 is developed for the treatment of patients with advanced solid tumors and lymphomas, and it is undergoing a phase I clinical trial of safety and tolerability for cancer patients.
| Appearance | Solid Powder |
|---|---|
| Purity | NLT 98% |
| Storage | Store in a cool and dry place and at 0-4 ºC for short term (days to weeks) or -66 ºC for long term (months to years). |
*The above information is for reference only.